TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

Similar documents
Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers.

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

Genetic testing all you need to know

A Review from the Genetic Counselor s Perspective

Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer

Serrated Polyps and a Classification of Colorectal Cancer

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!

Lynch Syndrome Screening for Endometrial Cancer: Basic Concepts 1/16/2017

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Familial and Hereditary Colon Cancer

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Familial and Hereditary Colon Cancer

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

The Next Generation of Hereditary Cancer Testing

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

Genetic Testing for Lynch Syndrome

Prior Authorization. Additional Information:

The Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

Lynch Syndrome. Angie Strang, PGY2

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Corporate Medical Policy

Development of Carcinoma Pathways

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

Management of higher risk of colorectal cancer. Huw Thomas

Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Case Study. Overview. Deleterious MLH1 mutation detected on sequencing 10/16/2014

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Genetic Testing for Lynch Syndrome And Other Inherited Colon Cancer Syndromes

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Section 2.0 Medicine Subsection 2.04 Pathology/Laboratory

National Medical Policy

COLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer

Colorectal cancer Chapelle, J Clin Oncol, 2010

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Genetic Testing for Inherited Susceptibility to Colon Cancer; Including Microsatellite Instability Testing. Original Policy Date

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Colon cancer: practical molecular diagnostics. Wade S. Samowitz, M.D. University of Utah and ARUP

Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr

Precision Genetic Testing in Cancer Treatment and Prognosis

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

General Surgery Grand Grounds

Inherited colon cancer and other inherited cancer predispositions. Dr Anne De Leener Centre de Génétique Humaine

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Hereditary Cancer Update: What do GPOs need to know?

Colon Cancer and Hereditary Cancer Syndromes

Objectives. Case Study #1 1/28/14. A Collaborative Practice Approach to Genetic Testing in Cancer: Translating Science Into Clinical Practice

DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document

A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

Cover Page. The handle holds various files of this Leiden University dissertation.

Diagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD

Universal Screening for Lynch Syndrome

Colorectal Carcinoma Reporting in 2009

What All of Us Should Know About Cancer and Genetics

Colon Cancer Update Christie J. Hilton, DO

The molecular genetics of colorectal cancer

Introduction. Why Do MSI/MMR Analysis?

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

Subject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

Immunotherapy for dmmr metastatic colorectal cancer. Prof.dr. Kees Punt Dept. Medical Oncology AUMC

To discuss. Predictive Value of BRCA Histology. Tumour morphology: BRCA-1. Hereditary breast-ovarian cancer (HBOC)

Primary Care Approach to Genetic Cancer Syndromes

Universal Screening for Lynch Syndrome in Women with Newly Diagnosed Endometrial Cancer

CLINICAL MEDICAL POLICY

Hereditary Cancer Syndromes

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Immunotherapy in Colorectal cancer

Genetic Aspects of Inherited colorectal cancer (CRC)

CLINICAL MEDICAL POLICY

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

ASSESSMENT OF MLH1 PROMOTER METHYLATION IN ENDOMETRIAL CANCER USING PYROSEQUENCING TECHNOLOGY OBJECTIVES

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Pathology perspective of colonic polyposis syndromes

Information for You and Your Family

Medical Benefit Effective Date: 04/01/12 Next Review Date: 01/13 Preauthorization* Yes Review Dates: 01/10, 01/11, 01/12

Objectives. Genetics in Cancer Treatment and Prevention. Genes

Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari

Doctors Newsletter ISSUE

Agenda 8:30 AM. Jennifer L. Hunt

Hereditary Aspects of Colorectal Cancer

Current Practices Regarding the Use of PMS2 Genetic Testing

Transcription:

TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer

What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial adenomatous polyposis (FAP), up to 1% MUTYH-associated polyposis (MAP), up to 1% Other rare syndromes, up to 4%

What's the Difference Between Sporadic and Hereditary Cancer? Hereditary Cancer Germline mutation Sporadic mutation At birth, one copy of the gene already carries a mutation Over time, a second sporadic mutation occurs and the cell loses tumor suppressor function Tumor develops Sporadic Cancer An individual without a hereditary cancer syndrome has no mutations at birth. Sporadic mutations can occur for a variety of reasons. These mutations accumulate over time and eventually occur in both copies of a gene important for cancer protection. Tumor develops

What's the Difference Between Germline and Somatic Mutations? WHAT IS TESTED? INHERITANCE RISKS inherited (germline) Blood or saliva Genes that are identical in all cells of your body Can be inherited and passed on to family members Linked to an increased risk for other cancer(s) tumor (somatic) Your tumor tissue for cancerspecific changes Not inherited and only present in your tumor cells. Cannot be passed to family members Does not increase your risk for other cancers Can impact your treatment

What is Lynch Syndrome? An estimated 1/279-1/440 Americans has Lynch syndrome Caused by inherited mutations in a mismatch repair (MMR) gene (MLH1, MSH2, MSH6, PMS2) or EPCAM Causes increased risks of certain cancers, including colorectal and uterine. Identifying patients with Lynch syndrome is key to early detection and prevention. 19 Scheduled colonoscopy

Universal Screening: Using MSI/IHC to Find Patients with Lynch Syndrome Microsatellite Instability (MSI) Testing Looks for DNA instability in tumors, which is a feature of Lynch syndrome. Immunohistochemical (IHC) Analysis Looks for missing mismatch repair proteins in tumors, which is a sign of Lynch syndrome.

Microsatellite Instability Testing Sporadic CRC without MSI Sporadic CRC with MSI Lynch syndrome CRC Microsatellite CACACA CACACACACACACA CACACACACACA 1,800-1,600-1,400-1,200 - # of repeats 1,000-800 - 600-400 - 200-0 - -200 -

Immunohistochemistry (IHC) Absence of a Protein Suggests a Mutation in the Corresponding Gene MLH1 gene MSH2 gene MSH6 gene PMS2 gene MLH1 protein MSH2 protein MSH6 protein PMS2 protein Protein Present Missing Protein. Possible MSH2 gene mutation Missing Protein. Possible MSH6 gene mutation Protein Present

Historical Universal Screening MSI/IHC Abnormal Results Normal Results MLH1/PMS2 absent If additional tumor testing is negative MSH2 and/or MSH6 absent Lynch syndrome genetic testing if needed based on family history Additional tumor testing Lynch syndrome germline genetic testing to confirm diagnosis

Testing with TumorNet-Lynch MSI/IHC Abnormal Results Normal Results Germline Mutation Paired Tumor/Germline Testing Two Somatic Mutations Germline Lynch syndrome genetic testing if needed based on family history Lynch syndrome Rule out Lynch syndrome

TumorNet-Lynch what are we testing for? Tumor DNA Germline DNA (Blood or Saliva) Testing for somatic (tumor) mutations in the Lynch genes MLH1 Promoter Hypermethylation Analysis + + Microsatellite Instability (MSI) Analysis Germline genetic testing for Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) Comprehensive result to either confirm or rule out a diagnosis of Lynch syndrome

Possible Results from TumorNet-Lynch genetic test results meaning implications Germline mutation identified Diagnosis of Lynch syndrome Medical management based on cancer risks specific to gene mutation Targeted testing available to at-risk relatives Two somatic mutations identified Abnormal screening results eplained by changes isolated to tumor Rules out Lynch syndrome. Cancer risks and management based on personal and family history No germline mutation and no somatic mutations that eplain screening results Inconclusive result Cancer risks and management based on personal and family history 50339.5395_v1 05.30.18